| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |